SLS
SELLAS Life Sciences·NASDAQ
--
--(--)
--
--(--)
3.88 / 10
Netural
Fund-flow analysis shows a strong 7.76/10 score, with consistent inflows across block, medium, and large sizes, hinting at institutional accumulation. Analyst sentiment is overwhelmingly bullish (100% Strong Buy) but based on a single report with zero historical win rate, limiting reliability. Together, positive money flow and rare bullish calls add tail-winds, yet the thin analyst base warrants skepticism.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-07-16
InstitutionMaxim Group
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of SLS?
- SLS holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.88/10 (Netural).
